Partner Content: Highlights
Top videos
Events & Jobs
Upcoming events
Current jobs
Current CME continuing education
View Post

Scleroderma – Current recommendations for diagnosis and therapy 2025

Early detection is critical for treatment options of this multisystem disease with cutaneous involvement. Raynaud’s attacks are often in early stages and should always be further evaluated. Advances in research into the pathomechanisms of systemic sclerosis may make it possible to offer new targeted personalized therapies in the not too distant future…. Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitretenAlready a member? Log in here
View Post

Colorectal cancer screening – an update

Colorectal cancer is a relevant disease for society: every twentieth person in Switzerland is affected at least once in their lifetime. In Switzerland, around 4300 new cases occur every year and around 1700 people die from it. The mortality rate is around 40%, and 10% of all cancer deaths are caused by colorectal cancer…. Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitretenAlready a member? Log in here
View Post

What screening tools are helpful?

In view of the new and mostly well-tolerated therapies, the palliative life and treatment time of oncological patients is increasingly extended. It is a major challenge to identify patients in need of palliative support in an accurate and needs-based manner, as recommended in guidelines. In the context of Germany and Switzerland, a distinction is made between general palliative care (APV) and specialized palliative care (SPV)…. Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitretenAlready a member? Log in here
View Post

Consideration of the tumor microenvironment opens up new treatment options

Low-grade gliomas are among the most common primary brain tumors in childhood and can affect patients for life, which is why early diagnosis involving the tumor microenvironment is of significant importance. An international study published in 2025, in which the researchers used imaging mass cytometry to examine over 100 tumor samples at the single-cell level, revealed new therapeutic approaches with the potential combination of blocking the immune checkpoint receptor TIM-3 expressed on myeloid cells with inhibition of the MAPK signaling pathway…. Dieser Inhalt ist nur für Benutzer der Gruppe: Medizinische Fachperson zugänglich Jetzt beitretenAlready a member? Log in here